INTRODUCTION
Microglia, which constitute 10-20% of glial cells, are the major immunocompetent phagocytic cells in the central nervous system. Microglial activation is increasingly recognized as an early step in the pathophysiological response to any form of insult, such as trauma, infection, ischemia and degenerative tissue changes. 1 They respond to various kinds of insults by NMDA-mediated excitatory neurotoxicity, caspase-activation related apoptosis and have been used as an early marker. 2 Activated microglia have been proposed to play a major role in the pathogenesis of a range of movement disorders including Parkinson's disease, multiple system atrophy, corticobasal degeneration, and Huntington's disease. 1 Thus, detection of microglial activation provides useful information on formal parameters of disease, such as accurate spatial localization of the disease process and rate of disease progression. Microglial activation often procedes reactions of other cell types in the brain, and hence is a very sensitive marker of neuronal insult. 
Corticobasal Degeneration (CBD)
In CBD, activated microglia have been shown to be associated closely with the extensive tau pathology found in affected basal ganglia, brainstem nuclei, and cortical regions. In the [ (Fig. 3) . 13 Tai YF et al. 
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CONCLUSION
Although the exact role of activated microglia in movement disorders is not known, it has been hypothesized that they can be a bystander of neuronal death.
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